UCLA Human Genetics

Gonda WestThe Department of Human Genetics is the youngest basic science department in the Geffen School of Medicine at UCLA. When the Department was launched just prior to the sequencing of the human genome, it was clear that the practice of genetics research would be forever changed by the infusion of massive amounts of new data. Organizing and making sense of this genomic data is one of the greatest scientific challenges ever faced by mankind. The knowledge generated will ultimately transform medicine through patient-specific treatments and prevention strategies.

The Department is dedicated to turning the mountains of raw genetic data into a detailed understanding of the molecular pathogenesis of human disease. The key to such understanding is the realization that genes not only code for specific proteins, but they also control the temporal development and maturation of every living organism through a complex web of interactions.

Tree outside GondaHoused in the new Gonda Research Center, the Department serves as a focal point for genetics research on the UCLA campus, with state of the art facilities for gene expression, sequencing, genotyping, and bioinformatics. In addition to its research mission, the Department offers many exciting training opportunities for graduate students, postdoctoral fellows, and medical residents. Our faculty and staff welcome inquiries from prospective students. We also hope that a quick look at our web pages will give you a better idea of the Department's research and educational activities.

Upcoming Seminars

Upcoming Special Courses

Department News

News Highlights

  • Dr. Sriram Sankararaman has been selected to receive a 2017 Sloan Research Fellowship.
  • Dr. Janet Sinsheimer is the recipient of the 2017 L. Adrience Cupples Award for Excellence in Teaching, Research, and Service in Biostatistics, given by Boston University.
  • Dr. Wayne Grody is a co-chair on a project backed by the ASCP, CAP, AMP, and ASCO to a establish clinical practice guideline focusing on molecular biomarker testing for patients with early or advanced colorectal cancer.